Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies
- PMID: 34464958
- DOI: 10.1038/s41586-021-03925-1
Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies
Abstract
SARS-CoV-2 infection-which involves both cell attachment and membrane fusion-relies on the angiotensin-converting enzyme 2 (ACE2) receptor, which is paradoxically found at low levels in the respiratory tract1-3, suggesting that there may be additional mechanisms facilitating infection. Here we show that C-type lectin receptors, DC-SIGN, L-SIGN and the sialic acid-binding immunoglobulin-like lectin 1 (SIGLEC1) function as attachment receptors by enhancing ACE2-mediated infection and modulating the neutralizing activity of different classes of spike-specific antibodies. Antibodies to the amino-terminal domain or to the conserved site at the base of the receptor-binding domain, while poorly neutralizing infection of ACE2-overexpressing cells, effectively block lectin-facilitated infection. Conversely, antibodies to the receptor binding motif, while potently neutralizing infection of ACE2-overexpressing cells, poorly neutralize infection of cells expressing DC-SIGN or L-SIGN and trigger fusogenic rearrangement of the spike, promoting cell-to-cell fusion. Collectively, these findings identify a lectin-dependent pathway that enhances ACE2-dependent infection by SARS-CoV-2 and reveal distinct mechanisms of neutralization by different classes of spike-specific antibodies.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.
Similar articles
-
Human surfactant protein D facilitates SARS-CoV-2 pseudotype binding and entry in DC-SIGN expressing cells, and downregulates spike protein induced inflammation.Front Immunol. 2022 Jul 28;13:960733. doi: 10.3389/fimmu.2022.960733. eCollection 2022. Front Immunol. 2022. PMID: 35967323 Free PMC article.
-
Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19.Front Immunol. 2021 Dec 22;12:732690. doi: 10.3389/fimmu.2021.732690. eCollection 2021. Front Immunol. 2021. PMID: 35003058 Free PMC article. Review.
-
DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist.PLoS Pathog. 2021 May 20;17(5):e1009576. doi: 10.1371/journal.ppat.1009576. eCollection 2021 May. PLoS Pathog. 2021. PMID: 34015061 Free PMC article.
-
Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.J Virol. 2020 Oct 14;94(21):e01062-20. doi: 10.1128/JVI.01062-20. Print 2020 Oct 14. J Virol. 2020. PMID: 32788194 Free PMC article.
-
Structural basis of severe acute respiratory syndrome coronavirus 2 infection.Curr Opin HIV AIDS. 2021 Jan;16(1):74-81. doi: 10.1097/COH.0000000000000658. Curr Opin HIV AIDS. 2021. PMID: 33186231 Review.
Cited by
-
Unprecedented selectivity for homologous lectin targets: differential targeting of the viral receptors L-SIGN and DC-SIGN.Chem Sci. 2024 Aug 27;15(37):15352-66. doi: 10.1039/d4sc02980a. Online ahead of print. Chem Sci. 2024. PMID: 39246372 Free PMC article.
-
Development of a rapid neutralizing antibody test for SARS-CoV-2 and its application for neutralizing antibody screening and vaccinated serum testing.Infect Med (Beijing). 2022 Apr 26;1(2):95-102. doi: 10.1016/j.imj.2022.04.003. eCollection 2022 Jun. Infect Med (Beijing). 2022. PMID: 38073878 Free PMC article.
-
Relevance of the Entry by Fusion at the Cytoplasmic Membrane vs. Fusion After Endocytosis in the HIV and SARS-Cov-2 Infections.Results Probl Cell Differ. 2024;71:329-344. doi: 10.1007/978-3-031-37936-9_16. Results Probl Cell Differ. 2024. PMID: 37996685
-
Evaluation of Convalescent Plasma in the Management of Critically Ill COVID-19 Patients (with No Detectable Neutralizing Antibodies Nab) in Kashmir, India.Healthcare (Basel). 2023 Jan 20;11(3):317. doi: 10.3390/healthcare11030317. Healthcare (Basel). 2023. PMID: 36766892 Free PMC article.
-
An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer.J Clin Invest. 2022 Jun 1;132(11):e159062. doi: 10.1172/JCI159062. J Clin Invest. 2022. PMID: 35472136 Free PMC article.
References
-
- Hou, Y. J. et al. SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract. Cell 182, 429–446.e14 (2020).
-
- Walls, A. C. et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181, 281–292.e6 (2020).
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
